Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease
- PMID: 53657
- DOI: 10.1016/s0140-6736(75)92657-4
Incidence and clinical significance of e antigen and antibody in acute and chronic liver disease
Abstract
"e" is a serum antigen associated with type-B hepatitis. It is found only in hepatitis B surface antigen (HBsAg) positive sera, but is antigenically distinct from HBsAg. e antigen was not detected in the serum of any of 99 cases of acute type-B hepatitis who recovered normally. Its antibody, anti-e, was found in 14 (14%). The antibody usually appeared before clearance of HBsAg and before appearance of HBsAb. Serum e was not detected in any of 29 symptom-free carriers of HBsAg, but 21 (73%) showed anti-e. Serum e was found in chronic active hepatitis (44%) and chronic persistent hepatitis (31%). The antibody, however, was detected in only 2 of 79 patients with chronic active hepatitis but in 7 (44%) of chronic persistent hepatitis. Serum e was not found in 5 patients with primary liver-cell carcinoma or 5 with inactive HBsAg-positive cirrhosis. The antibody was, however, found in all 5 of those with inactive cirrhosis and in 4 of the 5 with primary cancer. These results suggest that the presence of e antigen is associated with active and usually continuing liver disease. Anti-e, however, is associated with inactive liver disease and asymptomatic carriage of HBsAg, and its presence must be regarded as a valuable sign in predicting those who will escape progressive chronic liver disease.
Similar articles
-
Incidence and clinical significance of HBe antigen and antibody in HBsAg-positive various liver diseases.Gastroenterol Jpn. 1979 Dec;14(6):604-10. doi: 10.1007/BF02773719. Gastroenterol Jpn. 1979. PMID: 230994
-
The e antigen and antibody in the serum of patients with HBsAg-positive liver disease and in asymptomatic carriers.Ric Clin Lab. 1976 Jul-Sep;6(3):251-7. doi: 10.1007/BF02899972. Ric Clin Lab. 1976. PMID: 1025647
-
e System and intrahepatocelullar HBcAG and HBsAG in HBsAG positive patients with liver diseases and healthy carriers.Scand J Gastroenterol. 1977;12(3):325-30. doi: 10.3109/00365527709180935. Scand J Gastroenterol. 1977. PMID: 866995
-
[Hepatitis-associated antigen: clinical and immunological significance].Klin Wochenschr. 1972 Feb 1;50(3):125-38. doi: 10.1007/BF01486937. Klin Wochenschr. 1972. PMID: 4335527 Review. German. No abstract available.
-
[Immunology of liver diseases].Schweiz Med Wochenschr. 1987 Jul 18;117(29):1065-75. Schweiz Med Wochenschr. 1987. PMID: 3313682 Review. German.
Cited by
-
Persistence of e antigen as prognostic marker in acute hepatitis B.Infection. 1979;7(1):17-20. doi: 10.1007/BF01640550. Infection. 1979. PMID: 84794
-
Electron microscopy of hepatitis B virus components in chronic active liver disease.J Clin Pathol. 1979 Jun;32(6):590-600. doi: 10.1136/jcp.32.6.590. J Clin Pathol. 1979. PMID: 469016 Free PMC article.
-
e Antigen and antibody in outbreaks of hepatitis B in two renal dialysis units.J Clin Pathol. 1977 Aug;30(8):717-9. doi: 10.1136/jcp.30.8.717. J Clin Pathol. 1977. PMID: 599184 Free PMC article.
-
Effects of recombinant leukocyte interferon on serum immunoglobulin concentrations and lymphocyte subpopulations in chronic hepatitis B.J Clin Immunol. 1990 Jan;10(1):38-44. doi: 10.1007/BF00917496. J Clin Immunol. 1990. PMID: 2312667
-
Clinical aspects of viral hepatitis.J R Soc Med. 1978 Jun;71(6):430-2. doi: 10.1177/014107687807100608. J R Soc Med. 1978. PMID: 702483 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources